Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Keio University Research: Genomic Insights for Personalized Cancer Treatment


      News provided by

      Keio University

      Oct 18, 2024, 00:02 ET

      Share this article

      Share this article


      TOKYO, Oct. 18, 2024 /PRNewswire/ -- In a recent paper published in Cancer Discovery, Keio University's Sara Horie and her colleagues conducted an in-depth analysis of cancer driver alterations using genomic data from Japanese and international cohorts. The study elucidates the genomic landscape of Japanese patients and identifies significant genomic differences between Asian and white populations, providing valuable resources for cancer genomic medicine. These findings have important implications for appropriate patient selection in molecularly targeted therapies.

      Figure link and caption

       https://research-highlights.keio.ac.jp/2024/10/c.html

      Caption: [Fig. 1A, Fig. 4A, Fig. 5BC, from the paper [1]

      https://doi.org/10.1158/2159-8290.CD-23-0902

      Background

      The advent of next-generation sequencing (NGS) has transformed our understanding of cancer, enabling detailed analyses of genetic mutations driving cancer development. Large-scale genomic studies like The Cancer Genome Atlas (TCGA) and the AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) have been instrumental in identifying mutations that affect cancer progression. These efforts have been fundamental to the rise of precision medicine, which tailors treatment strategies to the unique genetic profile of each patient. 

      However, the majority of existing data primarily consist of white populations, with few studies focused on Asian populations. Horie and colleagues addressed this gap by analyzing cancer gene panel data from Japan's Center for Cancer Genomics and Advanced Therapeutics (C-CAT), which, as of December 2023, has collected data from 67,630 patients.

      Study focus and methodology

      This study presents a pan-cancer clinico-genomic analysis of 48,627 Japanese patients registered in C-CAT between June 2019 and August 2023. It compares the patterns of driver mutations between the C-CAT cohort and white patients in the GENIE cohort. Additionally, C-CAT, GENIE, and TCGA datasets consisting of more than 100,000 patients were integrated to uncover numerous co-occurring and mutually exclusive relationships between driver mutations across various cancer types.

      Key Findings

      • Genomic landscape and clinical actionability of Japanese cancer patients

      The study provides an overview of the genomic landscape across multiple cancer types in Japanese patients. It highlights the spectrum of driver mutations, fusions, and tumor mutation burden, along with their clinical actionability. Clinically actionable genetic alterations were identified in 15.3% of patients in the C-CAT cohort, with the highest frequencies observed in well-differentiated thyroid cancer.

      • Genetic differences between Asian and White populations

      A comparative analysis of the mutational landscape between Japanese and white populations revealed a significantly higher frequency of TP53 mutations in the Japanese cohort across multiple cancer types, suggesting potential racial differences in mutation prevalence. When assessing clinical actionability, the overall proportion of actionable genetic alterations was higher in the GENIE white cohort. This disparity is largely due to the C-CAT cohort including more cases of cancers with few targetable alterations, such as pancreatobiliary cancers, highlighting the need to explore alternative therapeutic approaches for these cancer types.

      • Co-occurrence and mutual exclusivity of driver mutations

      Through the integration of multi-cohort registry data, the research identified numerous co-occurring and mutually exclusive relationships of driver mutations. A key finding is the significant co-occurrence of epigenetic driver mutations in ten cancer types. Analysis of RNA-sequencing data from TCGA and CRISPR screening data from cell lines revealed that the accumulation of mutations in epigenetic regulators promotes cancer growth.

      Significance and Future Prospects

      This research provides valuable insights into the genetic differences in cancer patients from different racial populations, particularly between Japanese and white populations. The findings highlight the need for cancer treatment strategies that are tailored to the Japanese population, ensuring that advances in precision medicine are inclusive of diverse genetic profiles. The study serves as a foundation for improving cancer diagnosis and treatment in Japan, with future large-scale genomic research expected to further refine personalized treatment approaches.

      Reflecting on the study's impact, the authors state, "This research highlights the critical need to consider population-specific genetic profiles in cancer treatment. By understanding these unique genomic differences, we can significantly improve personalized therapies and outcomes for Japanese cancer patients, ensuring that precision medicine can benefit a broader range of patients."

      This research highlights the importance of continuing to explore genetic diversity in cancer research, as it plays a crucial role in advancing personalized treatments and improving patient outcomes globally.

      About the researchers

      Sara Horie - Graduate medical student
      School of Medicine

      Sara Horie graduated from the Keio University School of Medicine in 2016 and completed a senior residency program in gastroenterology. She subsequently joined the Division of Molecular Oncology at the National Cancer Center Research Institute in Tokyo, Japan, where she is now conducting research focusing on cancer genetics. Her work involves integrating large-scale datasets of clinico-genomic data, aiming to contribute to the understanding of the molecular mechanisms driving human cancers.

      Keisuke Kataoka - Professor
      School of Medicine

      Keisuke Kataoka is a professor of the Division of Hematology, Department of Medicine, Keio University School of Medicine. He is also a chief of the Division of Molecular Oncology at the National Cancer Center Research Institute in Japan. He received his M.D. and Ph.D. in medicine from the University of Tokyo. As a hematologist, he aims to delineate the entire picture of genetic aberrations and clarify the molecular pathogenesis in various cancers.

      Links

      • https://www.k-ris.keio.ac.jp/html/100015493_en.html
      • https://www.keio-med.jp/gastro/staff/index.html
      • https://www.keio-hematology.jp/

      Reference

      1. Horie, S. et al. Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases. Cancer Discovery 14, 786–803 (2024). 

      https://doi.org/10.1158/2159-8290.CD-23-0902

      Further information

      Office of Research Development and Sponsored Projects
      Keio University
      2-15-45 Mita, Minato-ku, Tokyo 108-8345 Japan
      Telephone: +81 (0)-3-5427-1678
      E-mail: [email protected] 

      Websites
      Keio University
      https://www.keio.ac.jp/en/
      Keio Research Highlights
      https://research-highlights.keio.ac.jp/

      SOURCE Keio University

      Modal title

      Also from this source

      Keio University Research: Study Reveals How Happiness and Health are Linked across Generations

      A person's happiness and health are associated with those of their parents, but these connections are far from inevitable. Researchers at Keio...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Publishing & Information Services

      Publishing & Information Services

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.